July 22, 2020
Welcome to the Verisys Weekly Newsletter highlighting the COVID-19 regulatory updates between July 15 - 21, 2020.
Verisys' Compliance Team gathers information from a variety of state and federal sources and updates our COVID-19 Resource Page daily with those updates. We have compiled the most recent updates from the past week in this email to assist your organization in serving patients during the pandemic and maintaining compliance as you bring additional providers on board to serve on the frontlines.
STATE BOARD REGULATIONS
Board of Pharmacy
07/17/2020: The following waivers have been extended:
- Remote Processing: Effective through September 22, 2020
- Requirements for Consulting Pharmacist to Make Quarterly Visits: Effective through September 22, 2020
- USP <797> Requirements Related to Use of PPE: Effective through September 22, 2020
Source: Pharmacy Law Waivers
Board of Medicine
07/15/2020: Amending and Extending Executive Orders D 2020 071 and D 2020 107 Concerning the Suspension of Statutes to Allow the Operation of Alternate Care Sites in Colorado Due to the Presence of COVID-19.
Source: Executive Order 2020-137
07/15/2020: Florida Agency for Health Care Administration has released hospital screening requirements for long-term care facility residents.
Source: Emergency Rule
Emergency Rule Clarification
Board of Nursing
An unlicensed graduate of an accredited basic nursing education program, who applies for initial licensure by examination may be temporarily authorized to practice as a Graduate Nurse-Registered Nurse (GN-RN or Graduate Nurse-Practical Nurse (GN-PN), pending the taking of NCLEX (subject to stipulations). This temporary authorization to practice remains in effect for the duration of the declared public health state of emergency.
Source: Graduate Nurse temporary licensure
This information has been gathered from a variety of sources. Although Verisys has made every effort to provide complete, accurate and up-to-date information, Verisys makes no warranties, express or implied, or representations as to the accuracy or reliability of this information. The information is fluid and evolving. Verisys assumes no liability or responsibility for any errors or omissions in the information contained in this resource.
The information contained in this newsletter comprises all the information that we have found during those dates. It may not constitute a complete list of every regulation instituted by every board during the last week.
The Verisys Team